The aims of the current study were to investigate GLP-1 RA use, patient characteristics associated with their use, and its associations with mortality/morbidity in an unselected cohort of HF patients with T2DM across the EF spectrum. This evidence concerns the gene GLP1R and hydrops fetalis.